Canada’s Blind Spot on Drug Safety in Pregnancy – SOGC
The Society of Obstetricians and Gynaecologists of Canada (SOGC) shared a post on LinkedIn:
“A new op-ed published in the Montreal Gazette, co-authored by SOGC CEO Dr. Diane Francoeur and SOGC member Prof. Anick Bérard, highlights a critical gap in women’s health: the lack of robust data on the safety of medications during pregnancy.
Dr. Francoeur and Prof. Bérard note that most prescription drugs approved in Canada lack adequate safety data for use in pregnancy, leaving patients and physicians to make important decisions without clear evidence.
They call for stronger national data infrastructure, sustained investment in women’s health research and better integration of real-world evidence to change behaviour and improve outcomes.
Read the full op-ed.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 26, 2026, 13:17Receiving Lab Results Is Not the Same as Understanding Them – PCOS Awareness Association
-
Jul 26, 2026, 13:08The SMFM Global 26 Schedule is Officially Live! – The Society for Maternal-Fetal Medicine
-
Jul 26, 2026, 13:06Dale Goss: Multi-Centre Study Shows the Promise of AI-Assisted Rare Sperm Searching!
-
Jul 26, 2026, 12:13Ruman Bashir: Why First-Trimester Ultrasound Remains the Gold Standard?
-
Jul 26, 2026, 12:08Marco Zaccaria: When a Uterine Fibroid Twists, Recognizing a Surgical Emergency!
-
Jul 26, 2026, 12:06Correlation of BRCA and HRD Status With Clinical and Survival Outcomes in Ovarian Cancer – IJGC
-
Jul 26, 2026, 11:45Devyanshi Dixit: Knowledge About Labour, Myths vs Truth!
-
Jul 26, 2026, 11:34From the First IVF Birth to the Future of Fertility Care! – ESHRE
-
Jul 26, 2026, 11:09Sean Lauber: Can Probiotics Increase Your Chances of Pregnancy During IVF?
